Acacia Pharma has a late-stage pipeline of product candidates in development for post-operative and cancer supportive care; large and growing markets with significant unmet medical need.
Post-operative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
Initiation Of Second Pivotal Phase 3 Treatment Trial With BAREMSIS™ (APD421) In PONV
Positive Results From Second Pivotal Phase 3 Prophylaxis Study Of BAREMSIS™ (APD421) In PONV
Dr Patrick Vink To Succeed Ian Kent As Non-Executive Chairman
View all news